0
0
6/16/23 at 6:14pm
Organization
CNBC
Author
Annika Kim Constantino
44 words
0
Comments
The FDA's decision is a win for vaccine makers Pfizer, Moderna and Novavax, which have all been developing versions of their Covid shots to target XBB.1.5.
You are the first to view
https://www.cnbc.com/2023/06/16/fda-covid-shots-should-target-omicron-subvariant-xbbpoint1point5-this-fall.html
Create an account
or login to join the discussion